Specchio 2004.

Study characteristics
Methods	A multi‐centre, non‐randomised, uncontrolled, prospective before‐after study (Italy) Baseline period: not reported Treatment period: 4 months
Participants	45 people with focal epilepsy, and exceeding or equal to 20 on the MADRS 31 females and 14 males Mean age of 42.7 years
Interventions	Citalopram 20 mg per day
Outcomes	1) Seizure frequency 2) Improvement in depression measured by MADRS and Zung‐SDS 3) Adverse effects
Notes	39 participants received intended treatment and analysed